Wir sind mit live! Mehr erfahren

Novanta

NOVT

Börsenwert 4,87 Mrd. $

128,79 USD

-6,01

4,46 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

1 Tag

-4,46 %

5 Tage

-8,47 %

1 Monat

-3,02 %

3 Monate

-13,95 %

6 Monate

2,3 %

Seit Jahresbeginn

15,88 %

1 Jahr

20,8 %

5 Jahre

-20,85 %

10 Jahre

627,63 %

Profil: Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Mitarbeiter: 3.000

Technologie Wissenschaftliche und technische Instrumente

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 52,9 %

Neutral 47,1 %

Negativ 0 %

How to Invest in AI Drug Discovery

.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.

How to Invest in AI Drug Discovery

Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conf.

Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call

How to Build a Humanoid Body

Last month we broke down the three key areas needed to build your own humanoid. We have already looked at the companies behind the technologies required to build a humanoid's brain.

How to Build a Humanoid Body

Zacks Investment Research

Are Robots the New Normal? Bet on these ETFs to Invest in the Future

Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.

Are Robots the New Normal? Bet on these ETFs to Invest in the Future

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a.

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

How to Build a Humanoid Brain

In our previous guide to building a humanoid robot, we mapped out the three essential pillars of the project: the brain, the body, and the energy systems. Now, it is time to look closer at the brain.

How to Build a Humanoid Brain

Zacks Investment Research

Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why

Zacks Investment Research

Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice

Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice

Novanta Q2 Earnings Call Highlights

Novanta NASDAQ: NOVT reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July closing of its Riverpoint Medical acquisition.

Novanta Q2 Earnings Call Highlights

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt